These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 232190)

  • 1. Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells.
    Rymo L
    J Virol; 1979 Oct; 32(1):8-18. PubMed ID: 232190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.
    King W; Van Santen V; Kieff E
    J Virol; 1981 May; 38(2):649-60. PubMed ID: 6165836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus RNA in Burkitt tumor tissue.
    Dambaugh T; Nkrumah FK; Biggar RJ; Kieff E
    Cell; 1979 Feb; 16(2):313-22. PubMed ID: 222455
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus-specific RNA. I. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid cell lines.
    Hayward SD; Kieff ED
    J Virol; 1976 May; 18(2):518-25. PubMed ID: 178893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-barr virus-specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive, and prooductive infections.
    Orellana T; Kieff E
    J Virol; 1977 May; 22(2):321-30. PubMed ID: 194056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells.
    Arrand JR; Rymo L
    J Virol; 1982 Feb; 41(2):376-89. PubMed ID: 6281455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells.
    Heller M; Dambaugh T; Kieff E
    J Virol; 1981 May; 38(2):632-48. PubMed ID: 6264134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection.
    Powell AL; King W; Kieff E
    J Virol; 1979 Jan; 29(1):261-74. PubMed ID: 219221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro.
    Sugden B
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4651-5. PubMed ID: 200925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji.
    Polack A; Delius H; Zimber U; Bornkamm GW
    Virology; 1984 Feb; 133(1):146-57. PubMed ID: 6322426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of Epstein-Barr virus DNA obtained from superinfected Raji cells for complementary RNA hybridization studies.
    Tanaka A
    J Gen Virol; 1977 Feb; 34(2):375-9. PubMed ID: 190349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epstein-Barr virus DNA in human tumor cells].
    Schulte-Holthausen H; zur Hausen H
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):47-51. PubMed ID: 4145629
    [No Abstract]   [Full Text] [Related]  

  • 13. Linear association between cellular DNA and Epstein-Barr virus DNA in a human lymphoblastoid cell line.
    Adams A; Lindahl T; Klein G
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2888-92. PubMed ID: 4355371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.
    Shaw JE; Levinger LF; Carter CW
    J Virol; 1979 Feb; 29(2):657-65. PubMed ID: 219253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent DNA of Epstein-Barr virus: separation from high-molecular-weight cell DNA in a neutral glycerol gradient.
    Tanaka A; Nonoyama M
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4658-61. PubMed ID: 4373725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of restriction endonuclease fragments of intracellular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC-37, and F-265 human lymphoid cell lines.
    Rymo L; Lindahl T; Povey S; Klein G
    Virology; 1981 Nov; 115(1):115-24. PubMed ID: 6270894
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus DNA in human lymphoid cell lines: in vitro conversion.
    Andersson M; Lindahl T
    Virology; 1976 Aug; 73(1):96-105. PubMed ID: 183361
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.
    Raab-Traub N; Dambaugh T; Kieff E
    Cell; 1980 Nov; 22(1 Pt 1):257-67. PubMed ID: 6253079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of infection by Epstein-Barr virus. II. Comparison of viral DNA from HR-1 and superinfected Raji cells by restriction enzymes.
    Lee YS; Yajima Y; Nonoyama M
    Virology; 1977 Aug; 81(1):17-24. PubMed ID: 196398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.